Calumet stock experienced a volatile day after releasing Q3 2025 earnings, with sales down 2% to $1.1 billion, but profits soaring to $3.61 per share from a year-ago loss. The company will restate Q2 financials, increasing operating cash flow by $80 million. Despite positive earnings, Calumet remains unprofitable over the last 12 months, making investment risky until fixed. The Motley Fool’s Stock Advisor team did not include Calumet in their top 10 stock picks, known for substantial returns compared to the S&P 500. Consider all factors before investing in Calumet.

Read more at Yahoo Finance: Why Calumet Stock Is Up and Down Today